Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

Downton T, Zhou F, Segara D, Jeselsohn R, Lim E

Drug Design, Development and Therapy 2022, 16:2933-2948

Published Date: 2 September 2022